Connie Roe, APRN
Adult Health · Kansas City, KSNPI 1578912085
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations.
Across 62 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calliditas Therapeutics US Inc.$181
- Bayer$155
- Amgen$148
- Daiichi Sankyo Inc.$90
- Novartis$85
- AstraZeneca$83
- plus $457 from 11 others
What the payments were for
- Food & beverage$1,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calliditas Therapeutics US Inc. | 8 | $181 |
| Bayer | 8 | $155 |
| Amgen | 6 | $148 |
| Daiichi Sankyo Inc. | 4 | $90 |
| Novartis | 4 | $85 |
| AstraZeneca | 5 | $83 |
| Vifor Pharma, Inc. | 4 | $79 |
| Akebia Therapeutics Inc | 4 | $77 |
| OPKO Pharmaceuticals, LLC | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Aurinia Pharma U.S., Inc. | 2 | $38 |
| Fresenius USA Marketing, Inc. | 2 | $37 |
| Travere Therapeutics, Inc. | 4 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $17 |
| GSK | 1 | $14 |
How this compares
$1,199 in reported general payments places this provider in the 65th percentile of 155 adult health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 14 | $35,416 |
| ProsolParenteral Amino Acid 20% No.1 | 147 | $28,030 |
| KerendiaFinerenone | 25 | $19,358 |
| Sevelamer Carbonate | 64 | $17,694 |
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 37 | $9,006 |
| FarxigaDapagliflozin Propanediol | 12 | $6,546 |
| Calcium Acetate | 57 | $4,880 |
| ClinisolParenteral Amino Acid 15% No.5 | 17 | $2,719 |
| Calcitriol | 82 | $1,287 |
| Potassium Chloride | 48 | $741 |
| Amlodipine Besylate | 86 | $628 |
| Doxazosin Mesylate | 25 | $354 |
| Allopurinol | 72 | $333 |
| Losartan Potassium | 46 | $319 |
| Carvedilol | 36 | $278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Akebia Therapeutics IncAuryxia | $77 | $35,41614 claims |
| BayerKerendia | $155 | $19,35825 claims |
| AstraZenecaFarxiga | $83 | $6,54612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 155 adult health providers in Kansas.
Other adult health in Kansas City
- Jennifer SurpriseKansas City$8K
- Jenny PearsonKansas City$6K
- Barbara ThompsonKansas City$5K
- Katherine ChristensenKansas City$5K
- Kathryn PalmerKansas City$4K
- Kellie StewartKansas City$4K
- Sarah TurnbullKansas City$4K
- Ashleigh GentlesKansas City$3K
- Shirley VerbenecKansas City$3K
- Sally HauglandKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.